Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
NB003
regorafenib
Locations
9
China
The Second Hospital of Anhui Medical University
Hefei, Anhui, China
Beijing Cancer Hospital
Beijing, Beijing Municipality, China
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guandong, China
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
Xiangya Hospital, Central South University
Changsha, Huanan, China
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
Start Date
April 1, 2026
Primary Completion Date
August 1, 2028
Completion Date
September 1, 2028
Last Updated
January 30, 2026
NCT03375307
NCT05720117
NCT06066138
NCT04704661
NCT05058651
NCT05053971
Lead Sponsor
Ningbo Newbay Technology Development Co., Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions